Conflux Founders Hold Executive Roles at Pilot Pharmaceutical Biotech

Conflux founders Long Fan and Wu Ming are serving as executive directors at Pilot Pharmaceutical Biotechnology, a company listed on the Hong Kong Stock Exchange. Pilot Pharmaceutical Biotechnology has a market capitalization of approximately HK$371 million (US$47.26 million). Meanwhile, Conflux's native token, CFX, holds a market value of US$393 million, placing it 138th in the global cryptocurrency market rankings.

CFX +1.69%

Source: Show Original

Disclaimer: The content provided on Phemex News is for informational purposes only. We do not guarantee the quality, accuracy, or completeness of the information sourced from third-party articles. The content on this page does not constitute financial or investment advice. We strongly encourage you to conduct you own research and consult with a qualified financial advisor before making any investment decisions.

You may also like